Insiders · CHRO

CHRO insider transactions

Channel Therapeutics Corporation (CHRO) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for CHRO

• 335d
  SEC Form 4 filed by Director Baxter Richard B

  4 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
• 335d
  SEC Form 4 filed by Director Greenleaf Peter

  4 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
• 335d
  SEC Form 4 filed by Director Pauls Matthew

  4 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
• 335d
  SEC Form 4 filed by CFO, Treas & Secty Francis Knuettel Ii

  4 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
• 335d
  SEC Form 4 filed by Director Davis Todd C

  4 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
• 335d
  SEC Form 4 filed by Director Friedberg Ezra M

  4 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
• 335d
  SEC Form 4 filed by Director Malamut Richard

  4 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
• 335d
  SEC Form 3 filed by new insider Greenleaf Peter

  3 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
• 335d
  SEC Form 3 filed by new insider Pauls Matthew

  3 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
• 335d
  SEC Form 3 filed by new insider Baxter Richard B

  3 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
• 339d
  Director Friedberg Ezra M converted options into 80,000 shares (SEC Form 4)

  4 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
• 339d
  Chief Financial Officer Francis Knuettel Ii converted options into 10,000 shares (SEC Form 4)

  4 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
• 339d
  Director Davis Todd C converted options into 1,500,000 shares (SEC Form 4)

  4 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
• 340d
  Large owner Ligand Pharmaceuticals Inc converted options into 1,500,000 shares (SEC Form 4)

  4 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
• 340d
  SEC Form 3 filed by new insider Ligand Pharmaceuticals Inc

  3 - Pelthos Therapeutics Inc. (0001919246) (Issuer)
• 418d
  SEC Form 4 filed by Director Simmons Chia-Lin

  4 - Channel Therapeutics Corp (0001919246) (Issuer)
• 418d
  SEC Form 4 filed by CEO, Pres., CFO, Treas & Secty Francis Knuettel Ii

  4 - Channel Therapeutics Corp (0001919246) (Issuer)
• 569d
  SEC Form 4 filed by Director Davis Todd C

  4 - Chromocell Therapeutics Corp (0001919246) (Issuer)
• 569d
  SEC Form 4 filed by Director Malamut Richard

  4 - Chromocell Therapeutics Corp (0001919246) (Issuer)
• 569d
  SEC Form 4 filed by Director Friedberg Ezra M

  4 - Chromocell Therapeutics Corp (0001919246) (Issuer)
• 629d
  Director Malamut Richard bought $9,825 worth of shares (10,400 units at $0.94) (SEC Form 4)

  4 - Chromocell Therapeutics Corp (0001919246) (Issuer)
• 629d
  CEO, Pres., CFO, Treas & Secty Francis Knuettel Ii bought $5,044 worth of shares (5,200 units at $0.97) (SEC Form 4)

  4 - Chromocell Therapeutics Corp (0001919246) (Issuer)
• 633d
  CEO, Pres., CFO, Treas & Secty Francis Knuettel Ii bought $10,955 worth of shares (12,000 units at $0.91) (SEC Form 4)

  4 - Chromocell Therapeutics Corp (0001919246) (Issuer)
• 705d
  CEO, Pres., CFO Treas & Secty Francis Knuettel Ii gifted 20,000 shares, decreasing direct ownership by 4% to 515,510 units (SEC Form 4)

  4 - Chromocell Therapeutics Corp (0001919246) (Issuer)
• 705d
  Amendment: New insider Francis Knuettel Ii claimed ownership of 130,953 shares (SEC Form 3)

  3/A - Chromocell Therapeutics Corp (0001919246) (Issuer)
• 719d
  Amendment: SEC Form 4 filed by CEO, Pres., CFO Treas & Secty Francis Knuettel Ii

  4/A - Chromocell Therapeutics Corp (0001919246) (Issuer)
• 719d
  SEC Form 4 filed by Director Simmons Chia-Lin

  4 - Chromocell Therapeutics Corp (0001919246) (Issuer)
• 719d
  SEC Form 4 filed by Chief Medical Officer Lang Eric

  4 - Chromocell Therapeutics Corp (0001919246) (Issuer)
• 719d
  SEC Form 4 filed by Director Friedberg Ezra M

  4 - Chromocell Therapeutics Corp (0001919246) (Issuer)
• 719d
  SEC Form 4 filed by Director Malamut Richard

  4 - Chromocell Therapeutics Corp (0001919246) (Issuer)
• 719d
  SEC Form 4 filed by CEO, Pres., CFO Treas & Secty Francis Knuettel Ii

  4 - Chromocell Therapeutics Corp (0001919246) (Issuer)
• 719d
  SEC Form 4 filed by Director Davis Todd C

  4 - Chromocell Therapeutics Corp (0001919246) (Issuer)
• 817d
  Friedberg Ezra M bought $100,002 worth of shares (16,667 units at $6.00), increasing direct ownership by 3% to 545,721 units (SEC Form 4) (Amendment)

  4/A - Chromocell Therapeutics Corp (0001919246) (Issuer)
• 835d
  Davis Todd C exercised 29,167 shares at a strike of $4.80 (SEC Form 4)

  4 - Chromocell Therapeutics Corp (0001919246) (Issuer)
• 835d
  SEC Form 4 filed by Francis Knuettel Ii

  4 - Chromocell Therapeutics Corp (0001919246) (Issuer)
• 835d
  Friedberg Ezra M exercised 20,641 shares at a strike of $4.80 (SEC Form 4)

  4 - Chromocell Therapeutics Corp (0001919246) (Issuer)